APA (7th ed.) Citation

MR, W., VL, F., SM, K., AL, P., BN, S., TL, M., & TH, S. (2008). Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome. American journal of perinatology, 25(10), 637. https://doi.org/10.1055/s-0028-1090587

Chicago Style (17th ed.) Citation

MR, Wolfson, Funanage VL, Kirwin SM, Pilon AL, Shashikant BN, Miller TL, and Shaffer TH. "Recombinant Human Clara Cell Secretory Protein Treatment Increases Lung MRNA Expression of Surfactant Proteins and Vascular Endothelial Growth Factor in a Premature Lamb Model of Respiratory Distress Syndrome." American Journal of Perinatology 25, no. 10 (2008): 637. https://doi.org/10.1055/s-0028-1090587.

MLA (9th ed.) Citation

MR, Wolfson, et al. "Recombinant Human Clara Cell Secretory Protein Treatment Increases Lung MRNA Expression of Surfactant Proteins and Vascular Endothelial Growth Factor in a Premature Lamb Model of Respiratory Distress Syndrome." American Journal of Perinatology, vol. 25, no. 10, 2008, p. 637, https://doi.org/10.1055/s-0028-1090587.